Intravenous immune globulin in the therapy of peripartum cardiomyopathy

Journal of the American College of Cardiology

Volumn 34, Issue 1, 1999, Pages 177-180

  Bozkurt, Biykem ^a   Villaneuva, Flordeliza S ^b   Holubkov, Richard ^b,c   Tokarczyk, Tammy ^b   Alvarez Jr , René J ^b   MacGowan, Guy A ^b   Murali, Srinivas ^b   Rosenblum, Warren D ^b   Feldman, Arthur M ^b   McNamara, Dennis M ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; POLYCLONAL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MATERNAL MORBIDITY; MATERNAL MORTALITY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PUERPERIUM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CARDIOMYOPATHIES; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PUERPERAL DISORDERS; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0033165556     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00161-8     Document Type: Article

References (28)

1. Homans D.C. Peripartum cardiomyopathy. N Engl J Med. 312:1985;1432-1437.
2. Demakis J.G., Rahimtoola S.H. Peripartum cardiomyopathy. Circulation. 44:1971;964-968.
3. van Hoeven K.H., Kitsis R.N., Katz S.D., Factor S.M. Peripartum versus idiopathic dilated cardiomyopathy in young women - a comparison of clinical pathologic and prognostic features. Int J Cardiol. 40:1993;57-65.
4. Cunningham F.G., Pritchard J.A., Hankins G.D., et al. Peripartum heart failure idiopathic cardiomyopathy or compounding cardiovascular events . Obstet Gynecol. 67:1986;157-167.
5. Sanderson J.E., Adesanya C.O., Anjoran F.I., Parry E.H. Post-partum cardiac failure - heart failure due to volume overload. Am Heart J. 97:1979;613-621.
6. Marin-Neto J.A., Maciel B.C., Urbanetz L.L., et al. High output failure in patients with peripartum cardiomyopathy a comparative study with dilated cardiomyopathy . Am Heart J. 121:1991;134-140.
7. Lampert M.B., Lang R.M. Peripartum cardiomyopathy. Am Heart J. 130:1995;860-870.
8. Melvin K.R., Richardson P.J., Olson E.G., et al. Peripartum cardiomyopathy due to myocarditis. N Engl J Med. 307:1982;731-734.
9. Huerta E.M., Erice A., Espino R.F., et al. Post-partum cardiomyopathy and acute myocarditis. Am Heart J. 110:1985;1079-1081.
10. Midei M.G., DeMent S.H., Feldman A.M., et al. Peripartum myocarditis and cardiomyopathy. Circulation. 81:1990;922-928.
11. Rizeq M.N., Rickenbacher P.R., Fowler M.B., Billingham M.E. Incidents of myocarditis in peripartum cardiomyopathy. Am Heart J. 74:1994;474-477.
12. Demakis J.G., Rahimtoola S.H., Sutton G.C., et al. Natural course of peripartum cardiomyopathy. Circulation. 44:1971;1053-1061.
13. O'Connell J.B., Costanzo-Nordin M.R., Subramanian R., et al. Peripartum cardiomyopathy clinical hemodynamic, histologic and prognostic characteristics . J Am Coll Cardiol. 8:1986;52-56.
14. Wilin A.G., Mabie W.C., Sibai B.M. Peripartum cardiomyopathy an ominous diagnosis . Am J Obstet Gynecol. 176:1997;182-188.
15. Veille J.C. Peripartum cardiomyopathies a review . Am J Obstet Gynecol. 148:1984;805-818.
16. Brown C.S., Bertolet B.D. Peripartum cardiomyopathy a comprehensive review . Am J Obstet Gynecol. 178:1998;409-414.
17. Myocarditis Treatment Trial Investigators , Mason J.W., O'Connell J.B., Herskowitz A., et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med. 333:1995;269-275.
18. Dietrich G., Kaveri S.V., Kazatchkine M.D. Modulation of autoimmunity by intravenous immune globulin through interaction with the function of the immune/idiotypic network. Clin Immunol Immunopathol. 62:1992;S73-S81.
19. Drucker N.A., Colan S.D., Lewis A.B., et al. Gammaglobulin treatment of acute myocarditis in the pediatric population. Circulation. 89:1994;252-257.
20. McNamara D.M., Rosenblum W.D., Janosko K.M., et al. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. Circulation. 95:1997;2476-2478.
21. Foelich C.J., Goodwin J.S., Bankhurst A.D., Williams R.C. Pregnancy, a temporal fetal graft of suppressor cells in autoimmune disease. Am J Med. 69:1980;329-331.
22. Kovithavongs T., Dossetor J.B. Suppressor cells in human pregnancy. Transplant Proc. 10:1978;911-913.
23. Damek D.M., Shuster E.A. Pregnancy and multiple sclerosis. Mayo Clin Proc. 72:1997;977-989.
24. Christianson O.B., Mathieson O., Husth M., et al. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with i.v. immune globulin. Hum Reprod. 10:1995;2690-2695.
25. Kobashigawa J.A., Sabad A., Drinkwater D., et al. Pretransplant panel reactive antibody screens are they truly a marker for poor outcome after cardiac transplantation . Circulation. 94:(Suppl 9):1996;II294-II297.
26. McIntyre J.A., Higgens N., Britton R., et al. Utilization of intravenous immunoglobulin to ameliorate alloantibodies in a highly sensitized patient with a cardiac assist device awaiting heart transplantation. Fluorescence-activated cell sorter analysis. Transplantation. 62:1996;691-693.
27. Alarabi A., Backman U., Wikstrom B., et al. Plasmaphoresis in HLA immunosensitized patients prior to kidney transplantation. Int J Artif Organs. 20:1997;51-56.
28. Müller J., Wallukat G., Brandes K., et al. Successful therapy of idiopathic dilated cardiomyopathy by IgG immunoadsorption, results of a controlled study (abstr). J Am Coll Cardiology. 31:(Suppl 2):1998;67A.